LTS Corp

LTS Corp is a US-based subsidiary of Lohmann Therapie Systeme, headquartered in West Caldwell, New Jersey. The company employs 119 people and generates $371.3 million in annual revenue. LTS Corp specializes in the research and development of innovative drug delivery technologies. Their focus areas include LTS Transdermal and LTS Oral Thin Film technologies, as well as microneedle and 'active LTS Transdermal' technologies. These advanced systems aim to enhance and expand the capabilities of alternative drug delivery methods. LTS Corp is particularly known for its LTS Microneedles. These microneedles, designed to penetrate the skin's outer layer without causing irritation to nerves or blood vessels, enable the painless injection of larger molecules into the skin. By creating tiny holes in the skin's outermost layer, microneedles significantly increase the absorption rate of active substances. The company is actively researching various microneedle types, made from different materials and with diverse designs and sizes, to cater to a wide range of applications. To learn more about LTS Corp and its innovative drug delivery technologies, visit their website at lts-corp.com.